# Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

> **NCT06335914** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 30 (estimated)

## Conditions studied

- Advanced Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Ga 68 PSMA-11 PET
- **DIAGNOSTIC_TEST:** 18F-DCFPyL PET
- **DIAGNOSTIC_TEST:** FDG PET

## Key facts

- **NCT ID:** NCT06335914
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2029-03-04
- **Final completion:** 2029-09-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06335914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06335914, "Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06335914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*